Schranz Jennifer 4
4 · Nabriva Therapeutics plc · Filed May 4, 2020
Insider Transaction Report
Form 4
Schranz Jennifer
Chief Medical Officer
Transactions
- Tax Payment
Ordinary Shares
2020-04-30$0.55/sh−301$165→ 169,347 total
4 · Nabriva Therapeutics plc · Filed May 4, 2020
Ordinary Shares